Answers are grounded in this paper and cite their sources.
Background Fabry disease is an X-linked lysosomal storage disorder caused by variants in the GLA gene, with marked geographic variability in mutation spectra. While IVS4 + 919G > A is a well-established hotspot mutation in southern China, the genetic characteristics of northern populations remain poorly defined. Methods This multicenter study enrolled genetically confirmed Fabry disease patients from Shandong Province. Clinical, biochemical, and echocardiographic data were collected. GLA gene sequencing and family screening were performed. Clinical characteristics were further compared with those of patients carrying the IVS4 + 919G > A variant reported in the literature. In addition, PyMOL-based structural modeling was used to evaluate the impact of the c.454T > C variant on the three-dimensional structure of α-galactosidase A. Results A total of 22 probands were included, and 16 distinct GLA variants were identified. The c.454T > C variant was the most frequent (27.3%) and showed regional enrichment. The six carriers of c.454T > C exhibited a later-onset phenotype predominantly characterized by left ventricular hypertrophy, with some patients presenting renal involvement and severe cardiac events, along with marked intra-familial phenotypic heterogeneity. Compared with IVS4 + 919G > A carriers, patients with c.454T > C had a later age at diagnosis and more pronounced left ventricular hypertrophy, while both groups showed partially preserved α-galactosidase A activity and mild-to-moderate elevation of plasma lyso-Gb3. Structural analysis demonstrated that the Tyr152His substitution disrupts the local hydrogen-bonding network, potentially impairing protein stability. Conclusions The c.454T > C variant represents a relatively frequent GLA mutation in northern China with evidence of regional enrichment. It is associated with a later-onset, cardiac-dominant phenotype and marked intra-familial heterogeneity. These findings expand the genetic epidemiology of Fabry disease in China and provide a basis for region-specific screening strategies.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: